Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

Under pressure

Life science companies must prioritise their response to market changes

- PMLiVE

R&D productivity takes off

Approvals of NMEs reach heights last seen in the mid-1990s

- PMLiVE

GSK: We had a social responsibility to work on Ebola

And company says it delayed more commercialprojects to do so

- PMLiVE

Call for closer ties between pharma and animal health

One Health conference hears how joint workingcould benefit both sectors

- PMLiVE

23andMe expands into the drug discovery business

Firm will use its genetic data for its new research arm

- PMLiVE

UK Budget welcomed by life science industry

New measures include a £20m health funding boost for the north of England

- PMLiVE

US pharma market to reach $550bn by 2020

Health reforms and the new FDA initiatives among the factors that will help it grow

- PMLiVE

Nektar hit by breast cancer trial setback

NKTR-102 failed to meet phase III targets

- PMLiVE

Sanofi on track to refile Lyxumia in US

Study showed drug was equivalent to placebo in cardiovascular safety

NDA Group names general manager of new Switzerland operation

Stephanie Krumholz-Bahner has held numerous senior roles

- PMLiVE

Actavis completes $70.5bn Allergan acquisition

Finalisation comes after bidding war with deal-hungry Valeant

Anticipating the future in healthcare

New technologies will be key drivers for change

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links